Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Microglia of Prefrontal White Matter in Suicide
2014
Differential Serum Levels of Eosinophilic Eotaxins in Primary Sclerosing Cholangitis, Primary Biliary Cirrhosis, and Autoimmune Hepatitis
2013 StandoutNobel
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Helicobacter and atherosclerosis
1999
Classification and Grading of Gastritis
1996 Standout
Hepatocellular carcinoma
2016 Standout
Cystic fibrosis
2016 Standout
Accelerated Systemic Autoimmunity in the Absence of Somatic Hypermutation in 564Igi: A Mouse Model of Systemic Lupus with Knocked-In Heavy and Light Chain Genes
2017 StandoutNobel
Molecular targeted therapies in hepatocellular carcinoma†
2008
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Diagnosis and Management of Autoimmune Hepatitis
2010
Recurrence of autoimmune liver disease after liver transplantation: A systematic review
2006
Female Bias in Systemic Lupus Erythematosus is Associated with the Differential Expression of X-Linked Toll-Like Receptor 8
2015
Nutrition facts and functional potential of quinoa (Chenopodium quinoa willd.), an ancient Andean grain: a review
2010 Standout
Clinical features and management of primary sclerosing Cholangitis
2008
The natural history of recurrent hepatitis C and what influences this
2008
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Retransplantation in patients with hepatitis C recurrence after liver transplantation
2010
Liver transplantation: Current status and novel approaches to liver replacement
2001
An introduction to dietary/supplemental omega-3 fatty acids for general health and prevention: Part II
2005
Hepatitis C and Liver Transplantation: Enhancing Outcomes and Should Patients Be Retransplanted
2008
Oxidized LDL triggers changes in oxidative stress and inflammatory biomarkers in human macrophages
2017
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Herpes Viruses in Transplant Recipients: HSV, VZV, Human Herpes Viruses, and EBV
2010
Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: a controlled double‐blind trial
1995
Clinical Implications of Prostaglandin and Thromboxane A2Formation
1988
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
Gallbladder cancer: epidemiology and outcome
2014 Standout
Oxidative stress and neurodegeneration: where are we now?
2006 Standout
New therapeutic strategies for hepatitis C
2002 StandoutNobel
Cyclooxygenases, peroxide tone and the allure of fish oil
2005
Diagnosis and Management of Primary Sclerosing Cholangitis
2009
Neuroinflammation: the devil is in the details
2016 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Pharmacologic immunosuppression
2004
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
2009 Standout
Cystic fibrosis: An update for clinicians. Part 2: Hepatobiliary and pancreatic manifestations
2014
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia
2007 StandoutNobel
Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.
1994 Standout
Phase I/II study of PHY906/capecitabine in advanced hepatocellular carcinoma.
2009
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science
2019 Standout
A prospective study of intake of fish and marine fatty acids and prostate cancer.
2003
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
The Role of Vitamin D in Cancer Prevention
2005 Standout
Noninvasive monitoring of infection and rejection after lung transplantation
2015
Prevention of hepatitis C virus infection using a broad cross‐neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate
2015 StandoutNobel
The impact of hepatitis C burden: an evidence‐based approach
2014
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells
2013 StandoutNobel
Cutting Edge: Chronic Inflammatory Liver Disease in Mice Expressing a CD28-Specific Ligand
2012 StandoutNobel
The Continuing Challenges of Leprosy
2006 Standout
Works of Thomas W. Faust being referenced
Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms
2010
Severity of liver disease does not predict osteopenia or low bone mineral density in primary sclerosing cholangitis
2005
Varicella Infection Following Varicella Vaccination in a Liver Transplant Recipient
2002
An Overview of Solid Organ Transplantation
2005
Effect of prostaglandin F3α on gastric mucosal injury by ethanol in rats: Comparison with prostaglandin F2α
1989
MODERN IMMUNOSUPPRESSION
2000
Recurrent Primary Biliary Cirrhosis, Primary Sclerosing Cholangitis, and Autoimmune Hepatitis after Transplantation
2000
Liver transplantation in patients with cystic fibrosis
2010
Retransplantation for hepatitis C: Results of a U.S. multicenter retransplant study
2007
Recurrent primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis after transplantation
2001
Female mouse fetal loss mediated by maternal autoantibody
2012
The effects of indomethacin and hemorrhage on splanchnic blood flow
1982
Gastric and duodenal mucosal prostaglandin concentrations in gastric or duodenal ulcer disease: relationships with demographics, environmental, and histological factors, including Helicobacter pylori.
1992
Combination of capecitabine, oxaliplatin with bevacizumab in treatment of advanced hepatocellular carcinoma (HCC): A phase II study
2007